<DOC>
	<DOCNO>NCT00183404</DOCNO>
	<brief_summary>This study determine short- long-term safety effectiveness drug olanzapine ( ZyprexaÂ® ) reduce symptom autism child .</brief_summary>
	<brief_title>Long-Term Olanzapine Treatment Children With Autism</brief_title>
	<detailed_description>Autism serious childhood disorder significantly impair function development . Educational psychosocial program standard treatment autistic child , drug therapy often need well . Haloperidol drug commonly prescribe symptom autism . However , long-term administration haloperidol associate adverse effect blur vision , constipation , nausea . The investigation alternative drug treatment necessary . This study determine whether antipsychotic drug olanzapine may safe effective alternative haloperidol treat symptom autism child . This study last 36 week comprise 2 phase . In Phase I , participant randomly assign receive either olanzapine placebo 12 week . Participants respond treatment complete participation study . Participants respond assign Phase I treatment continue onto Phase II . All Phase II participant receive olanzapine daily 6 month . Self-report scale checklist use assess participant phase ; measure complete participant parent .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Diagnosis autism Parent guardian willing provide inform consent Uncontrolled seizure disorder Medical illness autism affect whole body Obesity History psychosis Impairment voluntary movement History olanzapine treatment</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Drug Treatment</keyword>
	<keyword>Child</keyword>
	<keyword>Olanzapine</keyword>
</DOC>